Study S001329

Sex Related Outcomes in Oral vs. Subcutaneous Semaglutide in Type 2 Diabetes Mellitus: A 12-month Real-world Study

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07056803
Study type: OBSERVATIONAL
Status: COMPLETED
Enrollment: 212
Start: 2024-01-01
Primary completion: 2024-06-25
Lead sponsor: University of Palermo
Conditions: Diabetes Mellitus Type 2
Interventions: DRUG:Oral semaglutide; DRUG:subcutaneous semaglutide
Results posted: FALSE
Individual participant data sharing: YES

Registered primary outcomes

Number of participants with HbA1c change [From enrollment to 12 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.